Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders

PHASE4CompletedINTERVENTIONAL
Enrollment

96

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

May 31, 2023

Study Completion Date

May 31, 2023

Conditions
Alcohol Use DisorderBipolar DisorderSchizoaffective Disorder Bipolar Type
Interventions
DRUG

Placebo

Inactive ingredient matching the active comparators in appearance.

DIETARY_SUPPLEMENT

Citicoline

Citicoline is an over-the-counter nutritional supplement that is used for neuroprotective effects. It is a naturally occurring neurochemical in the human body.

DRUG

Pregnenolone

Pregnenolone is a naturally occurring neurosteroid that is synthesized from cholesterol in the adrenal glands and also in the brain. Pregnenolone produces other neuroactive steroids.

Trial Locations (3)

33136

University of Miami, Miami

75390

UT Southwestern Medical Center, Dallas

78539

The University of Texas Rio Grande Valley, Edinburg

All Listed Sponsors
collaborator

University of Miami

OTHER

collaborator

University of Texas Rio Grande Valley

OTHER

lead

Sherwood Brown, MD, PhD

OTHER

NCT02582905 - Clinical Medication Development for Bipolar Disorder and Alcohol Use Disorders | Biotech Hunter | Biotech Hunter